Generic placeholder image

Inflammation & Allergy - Drug Targets (Discontinued)

Editor-in-Chief

ISSN (Print): 1871-5281
ISSN (Online): 2212-4055

The Inflammatory Response in Cardiac Surgery: An Overview of the Pathophysiology and Clinical Implications

Author(s): Vicente Corral-Velez, Juan C. Lopez-Delgado, Nelson L. Betancur-Zambrano, Neus Lopez-Sune, Mariel Rojas-Lora, Herminia Torrado and Josep Ballus

Volume 13, Issue 6, 2014

Page: [367 - 370] Pages: 4

DOI: 10.2174/1871528114666150529120801

Price: $65

Abstract

During cardiac surgery different factors, such as the aortic clamp, the extracorporeal circulation and the surgical injury itself, produce complex inflammatory responses which can lead to varying degrees of ischemia-reperfusion injury and/or systemic inflammatory response. This may have clinical implications due to hemodynamic changes related with an enlarged vasodilatory response. Thus, maintaining adequate levels of blood pressure during and after cardiac surgery represents a challenge for physicians when inflammatory response appears. The use of noradrenaline to raise arterial pressure is the most current pharmacological approach in the operating room and ICU. However, it is not always effective and other drugs, such as methylene blue, have to be used among others in specific cases as rescue therapy. The aim of our research is to review briefly the pathophysiology and clinical implications in the treatment of the inflammatory response in cardiac surgery, together with the mechanisms involved in those treatments.

Keywords: Cardiac surgery, cardiopulmonary bypass, systemic inflammatory response syndrome, vasopressors.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy